Biomarkers in Urology, An Issue of Urologic Clinics
- 1st Edition, Volume 50-1 - November 23, 2022
- Latest edition
- Editor: Adam Feldman
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 9 4 0 1 9 - 1
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 4 0 2 0 - 7
In this issue of Urologic Clinics of North America, guest editor Dr. Adam Feldman brings his considerable expertise to the topic of Biomarkers in Urology. The use of biomarkers in… Read more
Purchase options
In this issue of Urologic Clinics of North America, guest editor Dr. Adam Feldman brings his considerable expertise to the topic of Biomarkers in Urology. The use of biomarkers in clinical practice can range from screening, to refined detection in an at-risk population, to risk stratification following diagnosis, to prognostication following therapy. A better understanding of tumor biology and genetic heterogeneity will lead clinicians to adopt clinical paradigms that utilize sequences of biomarker assessments. In this issue, key experts help you remain at the forefront of the care of urologic malignancies by providing a timely update on emerging biomarkers in urology.
-
Contains 15 practice-oriented topics including biomarkers in pediatric urology; unleashing the urinary microbiome in benign urologic disease; biomarkers for detection and assessment of clinically significant prostate cancer; biomarkers in testicular cancer: classic tumor markers and beyond; and more.
-
Provides in-depth clinical reviews on biomarkers in urology, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Urology
Approaches and Barriers to Biomarker Discovery: The Example of Biomarkers of Renal Scarring in Pediatric Urology
Biomarkers in Urolithiasis
Biomarkers in Urethral Stricture Disease and Benign Lower Urinary Tract Disease
Pathophysiology and Clinical Biomarkers in Interstitial Cystitis
Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non–Muscle-Invasive Bladder Cancer
Biological Stratification of Invasive and Advanced Urothelial Carcinoma
The Association Between the Urinary Microbiome and Bladder Cancer
Combined Use of Magnetic Resonance Imaging and Biomarker Testing to Detect Clinically Significant Prostate Cancer
Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers
Targeted Molecular Imaging as a Biomarker in Urologic Oncology
Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond
The Evolving Landscape of Viral, Immune, and Molecular Biomarkers in Penile Cancer
Current and Future Biomarkers in the Management of Renal Cell Carcinoma
Biomarkers in Urolithiasis
Biomarkers in Urethral Stricture Disease and Benign Lower Urinary Tract Disease
Pathophysiology and Clinical Biomarkers in Interstitial Cystitis
Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non–Muscle-Invasive Bladder Cancer
Biological Stratification of Invasive and Advanced Urothelial Carcinoma
The Association Between the Urinary Microbiome and Bladder Cancer
Combined Use of Magnetic Resonance Imaging and Biomarker Testing to Detect Clinically Significant Prostate Cancer
Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers
Targeted Molecular Imaging as a Biomarker in Urologic Oncology
Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond
The Evolving Landscape of Viral, Immune, and Molecular Biomarkers in Penile Cancer
Current and Future Biomarkers in the Management of Renal Cell Carcinoma
- Edition: 1
- Latest edition
- Volume: 50-1
- Published: November 23, 2022
- Language: English
AF
Adam Feldman
Affiliations and expertise
Assistant Professor, Surgery, Harvard Medical School, Assistant in Urology, Urology, Massachusetts General Hospital, Harvard University, Dana-Farber/Harvard Cancer Center